Infection of cells expressing CXCR4 mutants lacking N-glycosylation at the N-terminal extracellular domain is enhanced for R5X4-dualtropic human immunodeficiency virus type-l

BMC Infectious Diseases

Volumn 2, Issue , 2002, Pages

  Thordsen, Ingo ^a   Polzer, Svenja ^a   Schreiber, Michael ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GLYCAN; GLYCOPROTEIN GP 120;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PROTEIN BINDING; PROTEIN GLYCOSYLATION; RECEPTOR BINDING; GENETIC TRANSFECTION; GENETICS; GLYCOSYLATION; MUTATION; PHYSIOLOGY; PLANT GROWTH; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

GLYCOSYLATION; HIV-1; HUMANS; MUTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CXCR4; TRANSFECTION; TROPISM; TUMOR CELLS, CULTURED;

EID: 2942527153     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-2-31     Document Type: Article

References (38)

1. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE and Hill CM Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-6
2. Feng Y, Broder CC, Kennedy PE and Berger EA HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-7
3. Lapham CK, Zaitseva MB, Lee S, Romanstseva T and Golding H Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5. Nat Med 1999, 5:303-8
4. Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP, Cheng-Mayer C, Robinson J, Maddon PJ and Moore JP CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 1996, 384:184-7
5. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA, Desjardin E and Newman W CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 1996, 384:179-83
6. Bandres JC, Wang QF, O'Leary J, Baleaux F, Amara A, Hoxie JA, Zolla-Pazner S and Gorny MK Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation. J Virol 1998, 72:2500-4
7. Mondor I, Moulard M, Ugolini S, Klasse PJ, Hoxie J, Amara A, Delaunay T, Wyatt R, Sodroski J and Sattentau QJ Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies. Virology 1998, 248:394-405
8. Sakaida H, Hori T, Yonezawa A, Sato A, Isaka Y, Yoshie O, Hattori T and Uchiyama T T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection. J Virol 1998, 72:9763-70
9. Chabot DJ and Broder CC Substitutions in a homologous region of extracellular loop 2 of CXCR4 and CCR5 alter coreceptor activities for HIV-1 membrane fusion and virus entry. J Biol Chem 2000, 275:23774-82
10. Kajumo F, Thompson DA, Guo Y and Dragic T Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the aminoterminal domain and the second extracellular loop of CXCR4. Virology 2000, 271:240-7
11. Malenbaum SE, Yang D, Cavacini L, Posner M, Robinson J and Cheng-Mayer C The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors. J Virol 2000, 74:11008-16
12. Li Y, Cuille-Rey MA and Hu SL N-linked glycosylation in the V3 region of HIV type 1 surface antigen modulates coreceptor usage in viral infection. AIDS Res Hum Retroviruses 2001, 17:1473-9
13. Geyer H, Holschbach C, Hunsmann G and Schneider J Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. J Biol Chem 1988, 263:11760-7
14. Mizuochi T, Spellman MW, Larkin M, Solomon J, Basa LJ and Feizi T Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. Biochem J 1988, 254:599-603
15. Polzer S, Dittmar MT, Schmitz H, Meyer B, Muller H, Krausslich HG and Schreiber M Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1. Glycobiology 2001, 11:11-9
16. Pollakis G, Kang S, Kliphuis A, Chalaby MI, Goudsmit J and Paxton WA N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J Biol Chem 2001, 276:13433-41
17. Ogert RA, Lee MK, Ross W, Buckler-White A, Martin MA and Cho MW N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J Virol 2001, 75:5998-6006
18. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, Miedema F and Tersmette M Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol 1992, 66:1354-60
19. Tersmette M, de Goede RE, Al BJ, Winkel IN, Gruters RA, Cuypers HT, Huisman HG and Miedema F Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 1988, 62:2026-32
20. Tersmette M, Gruters RA, de Wolf F, de Goede RE, Lange JM and Schellekens PT Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J Virol 1989, 63:2118-2125
21. Zhou H and Tai HH Characterization of recombinant human CXCR4 in insect cells: role of extracellular domains and N-glycosylation in ligand binding. Arch Biochem Biophys 1999, 369:267-76
22. Chabot DJ, Chen H, Dimitrov DS and Broder CC N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates. J Virol 2000, 74:4404-13
23. Baribaud F and Doms RW The impact of chemokine receptor conformational heterogeneity on HIV infection. Cell Mol Biol 2001, 47:653-60
24. Baribaud F, Edwards TG, Sharron M, Brelot A, Heveker N, Price K, Mortari F, Alizon M, Tsang M and Doms RW Antigenically distinct conformations of CXCR4. J Virol 2001, 75:8957-67
25. Orsini MJ, Parent JL, Mundell SJ, Benovic JL and Marchese A Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization. J Biol Chem 1999, 274:31076-86
26. Farzan M, Mirzabekov T, Kolchinsky P, Wyatt R, Cayabyab M, Gerard NP, Gerard C, Sodroski J and Choe H Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 1999, 96:667-76
27. Reitter JN, Means RE and Desrosiers RC A role for carbohydrates in immune evasion in AIDS. Nat Med 1998, 4:679-84
28. Chabot DJ, Zhang PF, Quinnan GV and Broder CC Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates. J Virol 1999, 73:6598-609
29. Zhong P, Peeters M, Janssens W, Fransen K, Heyndrickx L, Vanham G, Willems B, Piot P and van der Groen G Correlation between genetic and biological properties of biologically cloned HIV type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Retroviruses 1995, 11:239-48
30. McDonald RA, Chang G and Michael NL Relationship between V3 genotype, biologic phenotype, tropism, and coreceptor use for primary isolates of human immunodeficiency virus type 1. J Hum Virol 2001, 4:179-87
31. Hoffman NG, Seillier-Moiseiwitsch F, Ahn J, Walker JM and Swanstrom R Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop. J Virol 2002, 76:3852-64
32. Polzer S, Dittmar MT, Schmitz H and Schreiber M The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism and neutralisation.
33. Luo Z, Zhou N, Luo J, Hall JW and Huang Z The role of positively charged residues in CXCR4 recognition probed with synthetic peptides. Biochem Biophys Res Commun 1999, 263:691-5
34. McKnight A, Wilkinson D, Simmons G, Talbot S, Picard L, Ahuja M, Marsh M, Hoxie JA and Clapham PR Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J Virol 1997, 71:1692-6
35. Losman B, Biller M, Olofsson S, Schonning K, Lund OS, Svennerholm B, Hansen JE and Bolmstedt A The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant. FEBS Lett 1999, 454:47-52
36. Cecilia D, KewalRamani VN, O'Leary J, Volsky B, Nyambi P, Burda S, Xu S, Littman DR and Zolla-Pazner S Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol 1998, 72:6988-96
37. Morgenstern JP and Land H Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990, 18:3587-96
38. Strizki JM, Turner JD, Collman RG, Hoxie J and Gonzalez-Scarano F A monoclonal antibody (12G5) directed against CXCR-4 inhibits infection with the dual-tropic human immunodeficiency virus type 1 isolate HIV-1(89.6) but not the T-tropic isolate HIV-1(HxB). J Virol 1997, 71:5678-83